background: Recent studies indicate that round-headed sperm cannot activate oocytes and lack the postacrosomal sheath (PAS) or perinuclear theca (PT), although normal flat-headed sperm can activate oocytes and do have PAS (PT). In this study, we investigated how oocyte activation ability correlates with sperm head morphology (round and flat) and the presence of PT, by studying MN13, a representative molecule of the PT.
Introduction
Recent studies suggest that oocyte activation factor is stored as a component of a major cytoskeletal component, perinuclear theca (PT), in the mammalian sperm head (Perry et al., 1999; Saunders et al., 2002; Sette et al., 2002; Fujimoto et al., 2004; Manandhar and Toshimori, 2003 ; for reviews, Toshimori, 2009) . The PT, which shows resistance to extractions in non-denaturing detergents and high salt buffers, has a sub-cytoskeletal component, the postacrosomal sheath (PAS); (Longo et al., 1987; Olson and Winfrey, 1988; Toshimori et al., 1991) ; PAS is formed between the nuclear envelope and overlying plasma membrane at the postacrosomal region (Fig. 1) . Concerning the PT substance, a previous report showed that round-headed sperm of a globozoospermia patient lacked the PT substance in the posterior head, showing no immunostaining to a PT substance, calicin (Escalier, 1990) . In addition, we also reported that round-headed sperm of an animal model for human globozoospermia, the GOPC 2/2 (a required an artificial aid (electric stimulation) to activate oocytes after ICSI (Yao et al., 2002) . In addition, more recently, we reported that round-headed sperm of a globozoospermia patient lacked oocyte activation ability and required artificial aid (calcium ionophore) to activate oocytes after ICSI (Kyono et al., 2008) .
There have been several studies of oocyte activation-related molecules such as phospholipase C zeta (Saunders et al., 2002; Fujimoto et al., 2004; Yoda et al., 2004; Kouchi et al., 2005) , truncated c-kit (Sette et al., 2002) and MN13 (Manandhar and Toshimori, 2003) ; these molecules are thought to be stored as components of the PT substance, but their localization has yet to be clarified, owing to the paucity of good quality markers. Among them, however, the localization of MN13 is clear (Toshimori et al., 1991; Manandhar and Toshimori, 2003) ; MN13, specifically recognized by a MN13 monoclonal antibody, is present on the top of periodic structures that form the PAS (Fig. 1) .
On the other hand, during a series of studies using GOPC 2/2 mouse, we recently found that a small population (,5% in semen) of GOPC 2/2 sperm have rather flattened heads, even though these flat-headed sperm were classified into morphologically abnormal sperm. In general, the mutant sperm have round heads in .95% of the population; thus, the GOPC 2/2 male mouse is considered a good animal model for human globozoospermia (Yao et al., 2002) . Based on this background information, the aim of this study is to substantiate our hypothesis that oocyte activation ability of human and mouse sperm correlates with head flatness and presence of the PT substance. Analysis was performed, focusing on sperm head morphology (flat and round); the presence of MN13 as a representative molecule of the PT substance, and PAS formation, which is a representative structure confirming PT formation at the PAR. A unique point of interest is the materials used in this study: sperm from infertile patients with globozoospermia and teratozoospermia, and GOPC 2/2 mice, an animal model of human globozoospermia. To the best of our knowledge, there have been no investigations to date that address our hypothesis.
Materials and Methods
Human sperm: sample preparation and general characteristics Normal flat-headed sperm (control)
Sperm from a healthy volunteer man, 50 years old man with two children, were used as the flat-headed sperm control. Sperm were collected by masturbation after 3 days of abstinence. The semen volume was 2.5 ml with 80 Â 10 6 sperm/ml, and the proportion of normal sperm with flat heads was .80%, in agreement with World Health Organization (WHO) criteria (.60%, according to the Kruger's strict criteria). The sperm motility was .70%.
Round-headed sperm
Sperm from an infertile globozoospermia patient were collected as described above. The semen volume was 2 ml with 38 Â 10 6 sperm/ml, and the rate of round-headedness was 100%. The sperm motility was 39%. The sperm could not activate oocytes after ICSI and required artificial activation with calcium ionophore; the treatment history of this patient and the partial characterization of the round-headed sperm had been previously reported (Kyono et al., 2008) . The sperm not used for treatment were stored in SpermFreeze (FertiPro N.V., Beemen, Belgium) at 2808C until analyzed.
Flat and round-headed sperm from a teratozoospermia patient
Morphologically abnormal sperm, including flat and round-headed sperm, were collected from an infertile teratozoospermia patient. These sperm were collected as described above and characterized c.3 h after collection. The semen volume was 4.9 ml with 25 Â 10 6 sperm/ml in the concentration. The rate of abnormality was nearly 100%, according to WHO criteria, with various types of abnormal heads and tails. The motility was nearly 100%. These sperm were rinsed three times with TYH medium (Toyoda et al., 1971) and stored in R18S3 medium (180 mg Raffinose/ ml [Wako Pure Chemical Industries Ltd, Osaka, Japan] plus 30 mg skimmed milk/ml) at 2808C for further analyses.
Mouse sperm: sample preparation and general characteristics
Normal flat-headed sperm (control)
Sperm were collected from the cauda epididymides of male ICR mice (14-16 weeks old) purchased from the Takasugi Experimental Animal Supply Company (Saitama, Japan).
Round-headed sperm, which accounted for .95% of the population, were collected from the cauda epididymides of GOPC 2/2 mice. The GOPC 2/2 mutant mice were originally established in the Cancer Research (JFCR) Cancer Institute (Yao et al., 2002) . Other characteristics, excepting those outlined in this study, were previously reported (Yao et al., 2002; Ito et al., 2004; Suzuki-Toyota et al., 2004 , 2007 . As described in the Introduction, since we recently found that GOPC 2/2 sperm had rather flattened heads in .5% of the population, we termed these flat-headed sperm 'GOPC 2/2 flat-headed sperm' to differentiate them from wild-type flat-headed sperm. Therefore, typical round-headed sperm from GOPC 2/2 mice were called 'GOPC 2/2 round-headed sperm' and used subsequently.
Both GOPC 2/2 round-headed sperm and the round-headed sperm of the globozoospermia patient were examined to determine whether MN13 and PAS (PT) were present or not, using immunocytochemistry with MN13 antibody and electron microscopy, respectively. These two characteristics were compared with those of flat-headed sperm from wildtype mice and a healthy human volunteer; they were also examined in abnormal sperm, including round-headed sperm of a teratozoospermia patient. All mice used were sacrificed by deep anesthesia with pentobarbiturate (Nembutal, Dainippon Sumitomo Pharma, Osaka, Japan) or by neck dislocation. Live sperm were collected from the cauda epididymides and stored in R18S3 at 2808C until use.
Informed consent, animal handling and ethical approval
Written informed consent was provided by all donors before the experiments, in accordance with the ethics approval of our institutes. The individual names of the donors were encoded to hide personal information, and animal handling was performed in accordance with Chiba University guidelines for the care and use of laboratory animals and with the approval of the Animal Research Committee of the JFCR Cancer Institute and Chiba University.
Antibodies

Primary antibody
The monoclonal antibody MN13 [mouse immunoglobulin (Ig)M with m chain] used in this study was generally 1/10 000 dilution of a stock solution, 0.1 mg/ml final concentration. The MN13 antibody specifically recognizes the antigenic molecule MN13 present on the PAS ( Fig. 1) (Toshimori et al., 1991) . Functionally, MN13 is an oocyte activation-related molecule (Manandhar and Toshimori, 2003) thus the presence of MN13 is considered to denote presence of the PT substance (Fujimoto et al., 2004; Kitamura et al., 2004; Maekawa et al., 2004) .
Secondary antibody
Alexa Fluor 488 goat anti-mouse IgM (mchain) from Molecular Probes, Inc. (Eugene, OR, USA) was used as a secondary.
Other chemicals
A fluorescent dye, Hoechst 33258 (Sigma Aldrich, St. Louis, MO, USA) was used for nuclear staining. Pregnant mare's serum gonadotrophin (PMSG) (ASKA Pharmaceutical Co., Ltd, Tokyo, Japan) and hCG (ASKA Pharmaceutical), 5 IU each, were used to superovulate B6D2F1 female mice (Takasugi Experimental Animal Supply Company), to collect oocytes for the oocyte activation assay.
Differential interference contrast and fluorescence imaging
Observation with a differential interference contrast (DIC) and fluorescence system was performed with an Olympus BX50 (Olympus Co., Tokyo, Japan) microscope with a UPlanApo 100 Â NA 1.35 oil objective lens equipped with an imaging system comprising appropriate filters for fluorescence and a charge coupled device camera RETIGA Exi FAST 1394 (Qimaging, Surrey, Canada). Acquisition and storage of the data were controlled by SlideBook 4 software (Intelligent Imaging Innovations, Denver, CO, USA).
Indirect immunofluorescence assay with MN13 antibody
The Indirect immunofluorescence (IIF) assay was employed to determine the relationship between sperm head shape (flat or round) and presence of the MN13 molecule. Frozen spermatozoa were thawed in a water bath at 378C, washed with phosphate-buffered saline (PBS), and again frozen to permeabilize the plasma membrane and thus allow antibody penetration. The once-thawed sperm were attached to polylysine-coated slides; these sperm were incubated in PBS containing MN13 antibody at 48C overnight. The sperm were then rinsed twice in PBS and sequentially incubated in PBS containing Alexa Fluor 488 goat anti-mouse IgM (0.5 mg/ml) and Hoechst 33258 (1.5 mg/ml) at room temperature for 1 h. The samples were then rinsed twice in PBS, covered with a coverglass in a drop of PBS or mineral oil, and observed with an Olympus BX50 epifluorescent microscope as described above. Normal wild-type mouse sperm with flat heads were intentionally mixed into the samples of interest as internal controls.
Conventional transmission electron microscopy
Transmission electron microscopy (TEM) was employed to determine the relationship between sperm head shape (flat or round) and PAS (PT) formation. The thawed sperm were rinsed once in TYH medium and fixed with 2.5% glutaraldehyde in TYH medium at room temperature for 1 h. After being rinsed in 10 mM Hepes (Nacalai Tesque, Inc., Kyoto, Japan) buffer and then in distilled water, the sperm were postfixed with 1% OsO 4 in distilled water for 1 h and embedded in 2% agar. The sperm were sequentially dehydrated through graded ethanol and embedded in Epon 812. Ultrathin sections were cut with an ultramicrotome (Ultracut E; Reihert-Jung, Vienna, Austria) and stained with uranyl acetate and lead citrate. Samples were analyzed with a transmission microscope (JEOL 1200 EX, Tokyo, Japan).
Oocyte activation assay using ICSI
This assay was performed to determine the relationship between the shape of sperm head (flat or round) and ability to activate oocytes. To collect oocytes, 8-week-old female B6D2F1 mice were superovulated with i.p. injections of 5 IU PMSG, followed by an injection of 5 IU hCG 48 h later. At 14 h post-hCG, oocytes were collected from the oviducts and cultured in CZB medium (Chatot et al., 1989) containing 10 mM Hepes (CZB-H) in a humidified atmosphere of 5% (v/v) CO 2 in air at 378C. Cumulus cells were removed by a brief incubation with 1 mg/ml hyaluronidase (Sigma Aldrich) in CZB-H. For ICSI, GOPC 2/2 sperm were thawed and rinsed in CZB-H medium. GOPC 2/2 flat-headed sperm (,5% of the population) were carefully selected from roundheaded sperm (.95% of the population) and aspirated into a glass injection pipette. One or two faint piezo-electric pulses were administered with a piezo-micromanipulator (Micromanipulator 5171, EppendorfNetheler-Hinz GmbH, Hamburg, Germany; PMAS-CT150 Piezo Micro Manipulator Controller, PRIME TECH LTD, Ibaraki, Japan) to perforate the oolemma. The selected flat or round-headed sperm were then injected into ooplasm. After ICSI, the oocytes were cultured in CZB in a CO 2 incubator. Six hours later, oocyte activation status was assessed by the presence of clear pronucleus formation and the extrusion of a second polar body. This assay was repeated three times for the flat head and round-headed sperm.
Statistical analysis
The data for oocyte activation ability were expressed as mean + S.D. Significant differences in oocyte activation ability between groups was evaluated by the paired Students t-test. Differences with a probability value ,0.05 were considered significant.
Results
Relationship between sperm head shape (flat or round) and immunoreactivity to MN13 antibody in human and mouse sperm
In the sperm mixture sample, flat-headed sperm (internal controls) from a fertile volunteer man and a control mouse were immunopositive to MN13 antibody ( Fig. 2A) , although round-headed sperm from an infertile globozoospermia patient were negative to MN13 antibody (Fig. 2B) . We next confirmed these relationships in flat and roundheaded sperm from an infertile taratozoospermia patient. As expected, flat-headed sperm were immunopositive to MN13 antibody, although round-headed sperm were immunonegative. Although one case is shown in Fig. 2C of this study, this same result was found in more than 10 cases of teratozoospermia patients examined thus far (not shown).
Relationship between head shape and the presence of PAS in human sperm
We next examined the relationship between sperm head shape (flat or round) and the presence or absence of PAS in human samples by TEM. Flat-headed sperm had PAS at the PAR (Fig. 3A) , although round-headed sperm had no PAS ( Fig. 3B and C) .
Relationship between sperm head shape and immunoreactivity to MN13 antibody in GOPC 2/2 mice Since human flat-headed sperm had PAS and MN13 but round-headed sperm had neither PAS nor MN13, we next confirmed these relationships in GOPC 2/2 flat-headed sperm and GOPC 2/2 round-headed sperm by comparing IIF images with DIC images. As expected, GOPC 2/2 flat-headed sperm were immunopositive to MN13 antibody, although these sperm showed abnormal head shapes, to varying extents ( Fig. 4E and F) . In contrast, GOPC 2/2 round-head sperm ( Fig. 4C and D) were completely negative to MN13 antibody ( Fig. 4G and H) .
Relationship between sperm head shape and presence of PAS in GOPC 2/2 mice
We next examined whether PAS was present or not and how PAS differs between GOPC 2/2 flat-headed sperm and GOPC 2/2 roundheaded sperm by TEM. PAS was found to be present, or well developed, in GOPC 2/2 flat-headed sperm ( Fig. 5A and B) , and PAS was totally absent in GOPC 2/2 round-headed sperm (Fig. 5C ).
Oocyte activation ability (pronuclear formation rate) in GOPC 2/2 flat-headed or round-headed sperm
Since the presence of PAS was closely related to MN13-immunopositivity, a relationship between flatness of the sperm head and oocyte activation ability was strongly suggested. We therefore compared oocyte activation (pronuclear formation rate) in GOPC 2/2 flat-headed versus round-headed sperm, which were differentiated using a light microscope; this selection was not difficult owing to the uniqueness of the head shapes. In the first ICSI cycle, 17 of the 22 surviving oocytes into which GOPC 2/2 flat-headed sperm had been injected were activated (77%); meanwhile, none of the 20 surviving oocytes into which GOPC 2/2 round-headed sperm had been injected were activated (0%). For the second ICSI cycle, 11 of 15 (73%) and 0 of 20 oocytes (0%) were activated by injecting GOPC 2/2 flat-headed sperm and GOPC 2/2 round-headed sperm, respectively, and the corresponding data were 7 of 18 oocytes (39%) and 1 of 47 oocytes (2%) for the third cycle. Thus, the overall result was that pronucleus formation rate was significantly higher in GOPC 2/2 flat-headed sperm (77, 73, 39, 63% + 20.8) than in GOPC 2/2 round-headed sperm (0, 0, 2, 0.7% + 1.15, P , 0.05) (Fig. 6) . A summary of our data for the presence of PT substance, PAS (PT) formation and oocyte activation ability in human and mice sperm is shown in Table I . 
Discussion
In this study, we provide evidence that human flat-headed sperm contain MN13 ( Fig. 2A and C) and PAS (PT) (Fig. 3A) . Interestingly, this result was the same in the sperm of both a normal healthy human and wild-type mice, and even in the flat-headed sperm of GOPC 2/2 mice (Figs. 4E, F and 5A, B). In contrast, human and mutant mice, as shown in this study-it can be said that these three factors (i.e. the presence of PT substance, PAS (PT) formation and oocyte activation ability) correlate well in humans and mice (Table I) . The main diagnostic criterion of human globozoospermia is the presence of 100% round-headed sperm lacking the acrosome. The only successful treatment for human globozoospermia is ICSI, but the rate of successful fertilization increases only when oocytes are briefly treated with an additional oocyte activation stimulus (calcium ionophore) after ICSI (Battaglia et al., 1997; Rybouchkin et al., 1997; Kim et al., 2001; Tesarik et al., 2002; Kyono et al., 2008; Tejera et al., 2008) . Such is the case with GOPC 2/2 male mice, as previously reported (Yao et al., 2002; Toshimori and Ito, 2003; Ito et al., 2004) . Interestingly, however, although these acrosome-less, round-headed sperm have neither MN13, PAS (PT) nor oocyte activation ability, this study found that GOPC 2/2 flat-headed sperm contain MN13
and can activate oocytes. In this study, we analyzed round-headed sperm from one globozoospermia patient who had also been previously treated with ICSI; his sperm were successful in oocyte activation, but only with the aid of artificial activation in the mouse oocyte activation test (Kyono et al., 2008) . Kyono et al. (2008) reported that the oocyte activation ability rate (i.e. pronuclear formation rate) was 0% (0 oocytes/19 injected oocytes) when injected mouse oocytes were not artificially activated, whereas the rate was 68.4% (13 oocytes/ 19 injected oocytes) when the oocytes were artificially activated with SrCl 2 . Our present results indicate that human round-headed sperm possessing no activation ability have neither MN13 nor PAS (PT). Interestingly, we found the same result in mice: GOPC 2/2 round-headed sperm that had no immunoreactivity to MN13 antibody and no PAS (PT) had low, or no, oocyte activation ability (Table I) . Most interestingly, however, GOPC 2/2 flat-headed sperm-which were immunoreactive to MN13 antibody and 
contained PAS-were able to activate oocytes without the aid of any artificial activation (Fig. 6 ) but this oocyte activation was rather variable in the three ICSI cycles (77, 73 and 39%) using GOPC 2/2 flatheaded sperm, compared with that of the wild-type flat-headed sperm (unpublished data); this is presumably a result of the varying degree of head flatness in these gene-deletion mice. These lines of evidence support our hypothesis that oocyte activation ability correlates with head flatness and the presence of PT substance MN13 and PAS in both human and mouse sperm. In addition, there are many reports discussing the relationship between DNA integrity and pregnancy rate. For example, high DNA fragmentation affected embryonic development and fertilization rate (Huang et al., 2005; Velez de la Calle et al., 2008) . Therefore, sperm DNA integrity could be involved in the variable results described above. In order to further analyze this point, we are planning to study the DNA fragmentation rate of GOPC 2/2 sperm using techniques such as the terminal deoxynucleotidyl transferase-mediated digoxigenin-dUTP nick-end labeling (TUNEL) assay (Sun et al., 1997) . PAS is known to be a component of PT (Longo et al., 1987; Olson and Winfrey, 1988; Toshimori et al., 1991) . Previously, Escalier (1990) reported that the round-headed sperm of a human globozoospermia patient lacked PAS and showed no immunoreactivity to anti-calicin antibody; calicin is known to be a PT component protein in mammalian sperm heads. Thus, an absence or altered arrangement of calicin has been found in frequent forms of human teratozoospermia, such as 'round-headed' or other 'PAS defect' sperm malformations (von Bülow et al., 1995) . There are two reports showing that sperm head shaping is related to acrosome formation. When round spermatids failed to form an acrosome before reaching elongating spermatids, the nuclei could not elongate, causing round-headed sperm; this failure concomitantly disorganized the ectoplasmic specialization structure which connected Sertoli cells and developing head regions of elongating spermatids in globozoospermic model mice: Herb 2/2 mouse (Kierszenbaum et al., 2004) and GOPC 2/2 mouse . In addition, we also have immunogold electron microscopy data (unpublished) showing that acrosome formation is related to PT (or PAS) formation during spermiogenesis; the PT-identification molecule, MN13, was first transported to the outer surface of the outer acrosomal membrane, then to the marginal region formed at the most peripheral region of the acrosome, and then to the PAR to be organized into the PAS, as PT. By contrast, the control showed that any elongating spermatids of GOPC 2/2 mice were not immunostained with MN13 antibody. These lines of evidence strongly suggest that sperm head (acrosome) formation is related to formation of the PT (PAS); these data will be published elsewhere. Thus, PT (PAS) formation is probably very important for storing the oocyte activation substance.
In conclusion, to the best of our knowledge, this study is the first to show a correlation of oocyte activation ability with sperm head flatness and the presence of PT substance in both human and mouse sperm. A combined diagnosis of head flatness with immunocytochemical detection of PT substance will suggest the presence of oocyte activation ability, and is thus a potential test of sperm quality. In the longer term, this information may help facilitate the selection of good quality sperm, in terms of high oocyte activation ability, especially for ICSI purposes.
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